In addition, the frequencies of KRAS and GNAS mutations in IPMNs are highly variable according to the microscopic duct subtypes, reflecting their independent roles in the IPMN-adenocarcinoma sequence. The gene discussed is KRAS; the disease is pancreatic intraductal papillary-mucinous neoplasm.